Pfizer’s revenue grew 7.1% to ₹604 crore from ₹563 crore, while EBITDA increased 18.1% to ₹209.7 crore from ₹177.6 crore in Q1FY25. Shares of Pfizer Ltd ended higher on Wednesday (August 13) by 0.18% at ₹5,096.25 on the NSE.
Pfizer’s revenue grew 7.1% to ₹604 crore from ₹563 crore, while EBITDA increased 18.1% to ₹209.7 crore from ₹177.6 crore in Q1FY25. Shares of Pfizer Ltd ended higher on Wednesday (August 13) by 0.18% at ₹5,096.25 on the NSE.